Future-Proofing the Pharmaceutical Supply Chain with TMS
Examines regulatory, security, and fragmentation challenges in pharma logistics and explains how digital TMS solutions improve visibility, compliance, and resilience.
This white paper outlines current and emerging challenges in pharmaceutical transportation, including GDP compliance, temperature control, serialization, and multi-tier supplier networks. It details how patient-centric distribution models and global disruptions increase the need for agile, data-driven transportation management. The document positions TMS platforms as the foundation for secure documentation, real-time visibility, partner vetting, and cost optimization across complex pharma supply chains.
Pharma supply chains face strict GDP regulations, temperature control, and serialization requirements that demand precise documentation and audit readiness.
Fragmented supplier networks and postponement strategies create visibility gaps and hidden transportation costs.
Patient-centric and direct-to-patient models require agile, responsive supply chains supported by digital tools.
Global disruptions such as COVID-19 and container shortages exposed capacity and compliance risks unique to temperature-controlled pharma freight.
TMS platforms centralize documentation, enable real-time tracking, and support carrier vetting to reduce risk and improve resilience.
Market overview
Vendor landscape
Leaders
Implementation considerations
Want deeper analysis on vendors?
Related research
Research
Vendors
Company